[Treatment of chronic hypoxemia in COPD].

E. Weitzenblum

IF: 0.714

Revue des Maladies Respiratoires

Abstract:

What problem does this paper attempt to address?

P021 Higher TNFα and IL-6 mucosal levels in ulcerative colitis patients with more severe endoscopic activity

C Calviño Suárez,A L Martinez-Rodriguez,D Moreira-Alvarez,I Ardao-Palacios,M Duran-Rubi,R Ferreiro-Iglesias,I Baston-Rey,S Porto-Silva,L Nieto-Garcia,M J Varela-Liste,J M Brea-Floriani,J E Dominguez-Munoz,M Loza-Garcia,M Barreiro-de Acosta

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0151

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterised by colonic mucosa inflammation. Its clinical course is marked by alternating periods of relapse and remission that impair patients' quality of life. In the last decades, novel therapies have shown to be effective for UC resulting in lower rates of colectomy. However, there is still a significant proportion of non-responding patients that change from one treatment to another, being exposed to its potential adverse events. Thus, predictive factors of response to available drugs are needed to tailor the best treatment strategy for each patient. The aim of our study was to measure TNFα and IL-6 levels in colonic biopsies from patients with UC with moderate to severe endoscopic activity. Methods A prospective, observational single-centre study was designed and it is currently on going. Adult UC patients with moderate to severe endoscopic activity (Mayo Endoscopic Score (MES) > 1) in a routine colonoscopy were included. Biopsies from inflamed (MES>1) and non-inflamed (MES=0) colon of each patient were homogenised and processed by using RIPA buffer and ultrasounds to obtain cell lysates. Human Luminex Discovery Assay (2 plex) was used for the simultaneous detection and quantitation of IL-6 and TNFα. Data are shown as percentage, median, interquartile range (IQR) and mean ± standard deviation (SD) as appropriate. Results So far, 21 patients were consecutively included (mean age 53.8 years (SD 17.0), 52.4% female). About 43% of patients had left-sided UC, 28.5% extensive UC and 28.5% proctitis. Regarding endoscopic activity, 61.9% of patients showed MES=2 and 38.1% were MES=3. Fourteen patients (66.6%) were bio-naïve and 7 (33.3%) had been exposed to anti-TNFα. IL-6 was detected in biopsies from colon with MES ≥ 2 of 18 (85.7%) patients, of which 10 (55.6%) patients also TNFα was found. Neither IL-6 nor TNFα were detected in biopsies from non-inflamed colon (p=0.00). Median IL-6 in inflamed colonic samples from patients with MES-2 was 25.6pg/ml (IQR 0.2-74.3) and 92.2pg/ml (IQR 16.9-314.3) in those with MES-3 (p=0.09). Median TNFα in inflamed colonic biopsies from patients with MES-2 was 0.0pg/ml (IQR 0.0-20.0) and 22.2pg/ml (IQR 0.0-34.3) in patients with MES-3 (p=0.12) (Figure 1). No differences were found in TNFα levels between anti-TNFα naïve patients and those patients previously exposed to anti-TNFα (p=0.96). Conclusion IL-6 and TNFα are elevated in inflamed colonic mucosa, particularly in those patients with more severe endoscopic activity, while they are not found in non-inflamed colonic mucosa. The correlation between cytokine levels and endoscopic severity suggests their potential as biomarkers for treatment response.

gastroenterology & hepatology
Estimation of fertility-inhibiting indices using vital registration data.

M. El-khorazaty

Genus

Abstract: The Bongaarts model quantifies intermediate variables that have a direct impact on fertility and it is related to the classical analytic framework of intermediate fertility variables (IFVs) introduced by Davis and Blake. The model requires data on age-specific proportions of women currently married, age-specific fertility rates (ASFRs), estimates of postpartum infecundability, and proportion of women currently using effective contraceptive methods. Horne, El-Khorazaty, and Suchindran (1990) developed a childbearing model estimating projected ages at 1st and last birth (AFB, ALB) and the reproductive life span (RLS), making use of only ASFRs available from either vital statistics or sample surveys. The correspondence between Bongaarts-type indices of marriage, contraception, and infecundability and the childbearing indices is discussed. Data on both fertility-inhibiting and childbearing indices were available for 225 subpopulations. Application 1: Characterization of the fertility-inhibiting indices by the childbearing indices. Contraceptive practice is the major fertility-inhibiting factor among women who stop childbearing before age 35 years, but for those women who stop reproducing in their late thirties, long duration of breastfeeding is. Application 2: Decomposition of fertility decline by the childbearing indices. For societies with a low TFR of only 2 births, contraceptive use plays the major role in achieving this low fertility level, regardless of age at 1st birth, and age at last birth not exceeding 35 years. Application 3: Annual fertility-inhibiting indices using ASFRs. In Kuwait the TFR declined from 4.7 births in the early 1960s to well below 2 births in the late 1970s and 1980s owing to direct government support to family planning programs. The correspondence model, using only macro-level vital statistics data, can predict indirectly fertility-inhibiting indices on an annual basis for countries lacking the micro-level data necessary for estimating those indices directly.
[Kapandji-Sauvé procedure for chronic disorders of the distal radioulnar joint with special regard to the long-term results].

W. Daecke,A. Martini,N. Streich

DOI: https://doi.org/10.1055/S-2003-41976

2003-05-01

Abstract:We present the preliminary results of a retrospective study on 56 patients who underwent the Kapandji-Sauvé procedure for chronic disorders of the distal radioulnar joint (DRUJ). Outcome was assessed with special regard to the long-term results. The average follow-up was 5.9 years (1 to 12 years). 15 of the 56 operations were performed before 1996. Most procedures were performed because of secondary arthrosis or chronic dislocation of the DRUJ after distal radius fracture. Patients were assessed for pain, range of motion of wrist and forearm and radiological features. The DASH score and Mayo wrist score were used. Pain was improved in 94 % of the patients, but only 53 % were free of symptoms during heavy manual labour concerning the operated site. In four cases symptoms of ulnar impingement were found. Improvement in range of motion of wrist and forearm was significant. The post-operative DASH score was 22.6 +/- 20.0 and the Mayo wrist score was 79.5 +/- 14.6. One non-union of the DRUJ with consecutive fracture of the fixation screw and an algodystrophy in another case were found as postoperative complications. The only long-term complication consisted of a beginning humeroradial arthrosis ten years after the operation. The results demonstrate high patient satisfaction and reliable improvement in range of motion. Our results confirm the Kapandji-Sauvé procedure to be a reliable salvage procedure for arthrosis or chronic dislocation of the DRUJ even after long-term follow up.
Investigation of key miRNAs and their target genes in inflammatory bowel diseases and colitis-associated colorectal cancers using miRNA proifling and bioinformatic tools

Yuan YIN,Cheng WANG,Xin DAI,Zhaohui HUANG

DOI: https://doi.org/10.19401/j.cnki.1007-3639.2016.11.006

2016-01-01

Abstract:Background and purpose:Inlfammatory bowel diseases (IBD) are a group of chronic intestinal diseases, including ulcerative colitis (UC) and Crohn’s disease (CD). This study identified differentially expressed miRNAs in UC, CD and colitis-associated colorectal cancers (CAC) to explore their potential as novel molecular biomarkers. Methods:Tissue samples were taken from 13 UC patients, 3 CD patients, 12 CAC patients, and 8 age-and gender-matched healthy controls. The miRNA expressions were detected by real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) assay. Known targets of deregulated miRNAs were utilized using miRWalk 2.0 database, and subsequent bioinformatics analysis of these target genes was performed by DAVID software (GO-analysis, KEGG-analysis and BIOCARTA-analysis). Results:The data showed that miR-146a, miR-27a, miR-29a, miR-20a and miR-21 were upregulated in UC, CD and CAC tissues compared with normal control. Moreover, the target genes of these miRNAs were enriched in several key signal transduction pathways including cancer-related pathway and immu-nity-associated pathway. Conclusion:miR-146a, miR-27a, miR-29a, miR-20a and miR-21 may play important roles in the switching from IBD to CAC.
Investigating the association between the tissue expression of miRNA‐101, JAK2/STAT3 with TNF‐α, IL‐6, IL‐1β, and IL‐10 cytokines in the ulcerative colitis patients

Qazaleh Voshagh,Amir Anoshiravani,Amin Karimpour,Golnaz Goodarzi,Sadra Samavarchi Tehrani,Ozra Tabatabaei‐Malazy,Ghodratollah Panahi

DOI: https://doi.org/10.1002/iid3.1224

2024-03-24

Immunity Inflammation and Disease

Abstract:In western blot analysis, protein values were obtained through the ratio of target density/loading control (fold of control). The protein expression of the two groups was compared by using an unpaired t‐test. The values of the studied proteins in both patient and control groups did not change significantly, the p‐values of P‐STAT3, total STAT3, and JAK2 proteins were (p = .16), (p = .51), and (p = .4), respectively. The relative protein levels were normalized to the protein levels of β‐actin. Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease caused by numerous factors, such as immune system dysfunction and genetic factors. MicroRNAs (miRNAs) play a crucial role in UC pathogenesis, particularly via the JAK‐STAT pathway. Our aim was to investigate the association between miRNA‐101 and JAK2‐STAT3 signaling pathway with inflammatory cytokines in UC patients. Methods We enrolled 35 UC patients and 35 healthy individuals as the control group, referred to Shariati Hospital, Tehran, Iran. Patients were diagnosed based on clinical, laboratory, histological, and colonoscopy criteria. RNA and protein extracted from tissue samples. Real‐time PCR was used to assess the expression levels of miRNA‐101, interleukin (IL)‐1β, IL‐6, tumor necrosis factor (TNF)‐α, and IL‐10 genes, while western blot was employed to measure levels of P‐STAT3, total STAT3, and JAK2 proteins. Results Expression of pro‐inflammatory cytokines TNF‐α, IL‐1β, and IL‐6 significantly increased, while the expression of IL‐10 significantly decreased in the case group versus controls. Additionally, miRNA‐101 expression was significantly higher in UC patients. A significant correlation between miRNA‐101 and IL‐6 expression was observed, indicating their relationship and possible impact on cell signaling pathways, JAK2‐STAT3. No significant changes were observed in phosphorylated and total STAT3 and JAK2 protein expression. Conclusion This study provides evidence of increased miRNA‐101 expression in UC tissue, suggesting a potential correlation between miRNA‐101 and IL‐6 expression and their involvement in the JAK2‐STAT3 pathway. The study confirms alterations in UC patients' pro‐inflammatory cytokines and anti‐inflammatory IL‐10. However, further investigations are needed to understand the exact role of miRNA‐101 in UC pathogenesis fully.

immunology
P001 MicroRNA-155-5p contributes to the development of Ulcerative Colitis by regulating T lymphocyte proliferation and functions

N Sumiyoshi,T Toyonaga,A Shumway,F Nakagawa,M Tanaka,C Saeki,T Furey,S Sheikh,P Sethupathy,M Saruta

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0131

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background MicroRNA (miRNA) is a small non-coding RNA which regulate a variety of cell functions by suppressing target mRNAs in a post-transcriptional manner. Recent works have identified an increased expression of miR-155-5p in the colonic mucosa of UC patients. However, the role of miR-155-5p in the pathophysiology of UC remains understudied. This study aims to clarify the role of miR-155-5p in development of colitis in UC patients. Methods MiRNA and mRNA expression profiles in colon were compared between 15 UC and 5 healthy controls by running small RNA-sequencing (smRNA-Seq) and RNA-Seq on the matched colon tissue. Candidate target genes of miR-155-5p were identified by analyzing sequencing data sets using a statistical simulation method (miRhub). MiR-155-5p expressing cells were identified by in situ hybridization in combination with immunohistochemistry on inflamed colon tissue of UC patients. The impact of miR-155-5p on colonic inflammation was tested in the dextran sulfate sodium (DSS) -induced colitis model using miR-155 deficient mice. Results MiR-155-5p expression was significantly higher in the inflamed colonic tissue of UC patients than in healthy controls with more pronounced up-regulation in the treatment refractory UC patients compared to the treatment naïve UC patients (UC vs. healthy controls, log2FC = 0.83, adjusted p-value = 0.014). MiRhub analysis identified 10 candidate target genes of miR-155-5p including SHANK2, MYO1D, ADD3, AHCYL2, NR3C2, MIER3, TRIM2, GPD1L, SEMA5A, and SATB2 most of which were involved in cell proliferation and immune response (NR3C2, MIER3, TRIM2, GPD1L, SEMA5A, and SATB2). In situ hybridization identified a group of CD3 positive T lymphocytes with increased miR-155-5p expression in the inflamed colonic mucosa. MiR-155 deficient mice showed attenuated DSS-induced inflammation in colon compared to the control wild type mice (colon weight/length ratio, miR-155 deficient mice vs. controls, 27.2 vs. 44.6, p<0.01). Conclusion MiR-155-5p may contribute to the development of colitis in UC by regulating T lymphocyte proliferation and functions.

gastroenterology & hepatology
The Expressions of IL-2, IL-4, IL-17 and IL-10 in Ulcerative Colitis (UC) Mucosa and Its Relation with Disease Activity

YUE Wen-jie,LIU Yi,XU Wei,DONG Le,LUO Xiao-ting,JIANG Wei-ru,SUN Xu,ZHONG Liang,LIU Jie

DOI: https://doi.org/10.3969/j.issn.1672-8467.2012.05.003

2012-01-01

Abstract:Objective To investigate the expression of cytokines including IL-2,IL-4,IL-17 and IL-10 in the mucosa of patients with ulcerative colitis(UC),in order to determine the correlation between the expression levels of these cytokines and disease activity. Methods Thirty-six cases of UC were enrolled in this study.The disease activity was scored by Sutherland DAI in UC patients.Endoscopic mucosa biopsy was performed when UC patients took colonoscopy examination.The expression levels of cytokines including IL-2,IL-4,IL-17 and IL-10 in the intestinal mucosa were assessed by semiquantitative PCR.In 10 cases,these cytokines were measured by immunohisochemistry,and peripheral blood erythrocyte sedimentation rate(ESR) and c-reactive protein(CRP) were measured simultaneously. Results The expression level of IL-2 was significantly higher in inflamed mucosa than in normal mucosa,but there was no evident difference in protein expression of IL-2 among subgroups of UC patients classified by disease activity.However,the mRNA expression of IL-2 was higher in mild group than in moderate and severe.The expression level of IL-4 was higher in inflamed mucosa than in normal mucosa.Among subgroups of UC patients,the expression level of IL-4 was higher in severe than in mild and moderate.The expression level of IL-17 was higher in inflamed mucosa than in normal mucosa.Among subgroups of UC patients,the expression level of IL-17 was higher in severe than in mild and moderate.The protein and mRNA expression levels of IL-10 were higher in inflamed mucosa than in normal mucosa,but no statistical significance in the former.Among subgroups of UC patients,the expression level of IL-10 was higher in mild than in moderate and severe.No correlation was seen between the expression levels of those cytokines and ESR or CRP level. Conclusions Cytokines like IL-2、IL-4、IL-17 and IL-10 may be involved in the pathogenesis of UC through pro-or anti-inflammation effect.The mRNA expression levels of these 4 cytokines and protein expression levels of IL-4、IL-17 and IL-10 are correlated with disease activity of UC to some extent,and can be used to evaluate the activity of UC.
Explore on the Mechanism of miRNA-146a/TAB1 in the Regulation of Cellular Apoptosis and Inflammation in Ulcerative Colitis Based on NF-κB Pathway

Xiaoying Xia,Qian Yang,Xue Han,Yulin Du,Shujun Guo,Mengqing Hua,Fang Fang,Zhigang Ma,Hua Ma,Hui Yuan,Wenjing Tian,Zebang Ding,Yanan Duan,Qi Huo,Yao Li

DOI: https://doi.org/10.2174/0115665240273807231122052445

2024-02-12

Current Molecular Medicine

Abstract:Objective:: Ulcerative colitis (UC) is a chronic non-specific inflammatory disease of the rectum and colon with unknown etiology. A growing number of evidence suggest that the pathogenesis of UC is related to excessive apoptosis and production of inflammatory cytokines. However, the functions and molecular mechanisms associated with UC remain unclear. Materials and Methods: The in vivo and in vitro models of UC were established in this study. MiRNA or gene expression was measured by qRT-PCR assay. ELISA, CCK-8, TUNEL, and flow cytometry assays were applied for analyzing cellular functions. The interactions between miR-146a and TAB1 were verified by luciferase reporter and miRNA pull-down assays. Results:: MiR-146a was obviously increased in UC patients, DSS-induced colitis mice, and TNF-ɑ-induced YAMC cells, when compared to the corresponding controls. MiR- 146a knockdown inhibited the inflammatory response and apoptosis in DSS-induced colitis mice and TNF-ɑ-induced YAMC cells. Mechanistically, we found that TAB1 was the target of miR-146a and miR-146a knockdown suppressed the activation of NF-κB pathway in UC. More importantly, TAB1 could overturn the inhibitory effect of antagomiR-146a on cell apoptosis and inflammation in UC. Conclusion:: MiR-146a knockdown inhibited cell apoptosis and inflammation via targeting TAB1 and suppressing NF-κB pathway, suggesting that miR-146a may be a new therapeutic target for UC treatment

medicine, research & experimental
MIR-21 regulating distribution of intestinal flora through TNF-α promotes progression of ulcerative colitis

Yang Ke,Xueni Liu,Tao Niu,Zhao Qiang,Feng Gao

DOI: https://doi.org/10.5937/jomb0-43320

2024-04-23

Abstract:Background: To study the changes in intestinal flora in patients with ulcerative colitis (UC), and to explore its correlations with micro ribonucleic acid (miR)-21 and serum tumor necrosis factor-a (TNF-α). Methods: A total of 150 patients with UC were selected and divided into remission group and seizure group according to the severity of disease. At the same time, 150 healthy people receiving physical examination in the hospital during the same period were selected as control group. The levels of fecal miR-21 and TNF-α in all subjects were determined via reverse transcription-polymerase chain reaction (RT-PCR). The correlation between miR-21 and TNF-α and their associations with the changes in intestinal bacteria in UC were analyzed using Pearson correlation analysis. The risk factors affecting the occurrence of UC were explored via multivariate logistic regression analysis.
miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

Jing Zhou,Jialing Liu,Yangyang Gao,Liwei Shen,Sheng Li,Simin Chen

DOI: https://doi.org/10.3389/fphar.2021.707776

IF: 5.6

2021-07-09

Frontiers in Pharmacology

Abstract:Ulcerative colitis (UC) is a chronic non-specific inflammatory bowel disease, which usually manifests as abdominal pain, diarrhea and hematochezia. The disease often recurs and is difficult to cure. At present, the pathogenesis is not clear, but it is believed that the disease is caused by a complex interaction among immunity, heredity, environment and intestinal microflora disorders. MicroRNA (miRNA) is endogenous single-stranded non-coding RNA of 17–25 nucleotides (nts). They target the 3'Untranslated Region of a target gene and inhibit or degrade the target gene according to the extent of complementary bases. As important gene expression regulators, miRNAs are involved in regulating the expression of most human genes, and play an important role in the pathogenesis of many autoimmune diseases including UC. Studies in recent years have illustrated that abnormal expression of miRNA occurs very early in disease pathogenesis. Moreover, this abnormal expression is highly related to disease activity of UC and colitis-associated cancer, and involves virtually all key UC-related mechanisms, such as immunity and intestinal microbiota dysregulation. Recently, it was discovered that miRNA is highly stable outside the cell in the form of microvesicles, exosomes or apoptotic vesicles, which raises the possibility that miRNA may serve as a novel diagnostic marker for UC. In this review, we summarize the biosynthetic pathway and the function of miRNA, and summarize the usefulness of miRNA for diagnosis, monitoring and prognosis of UC. Then, we described four types of miRNAs involved in regulating the mechanisms of UC occurrence and development: 1) miRNAs are involved in regulating immune cells; 2) affect the intestinal epithelial cells barrier; 3) regulate the homeostasis between gut microbiota and the host; and 4) participate in the formation of tumor in UC. Altogether, we aim to emphasize the close relationship between miRNA and UC as well as to propose that the field has value for developing potential biomarkers as well as therapeutic targets for UC.

pharmacology & pharmacy
P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

J M Moon,K U Kim,E Lim,H W Hwang,K Kim,J Seo,S Y Shin,H Min,C H Choi

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0132

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background A growing body of evidence suggests that epithelial cell-derived microRNAs are involved in the pathogenesis of inflammatory bowel disease (IBD). This immunological impairment leads to altered colonic epithelial permeability and the release of inflammatory cytokines, such as IL-33. In this prospective cohort study, we studied the expression of epithelial cell-derived microRNAs (miRNA) in Crohn’s disease (CD) patients compared to healthy controls. We also investigated their potential role in regulating inflammation in experimental IBD animal models. Methods We prospectively collected terminal ileum tissue samples via ileocolonoscopy from non-IBD healthy control (n=26), CD patients in remission (n=34) and active CD patients (n=42). CD remission was defined as clinical remission with a Crohn’s disease activity index score of less than 150 and the achievement of endoscopic mucosal healing. Both inflamed and non-inflamed lesions were sampled in the active CD patients. miRNA levels were measured by small-RNA sequencing and also validated via qRT-PCR. Diagnostic abilities of specific miRNAs found were evaluated by receiver operating characteristic (ROC) curve analysis. A signature of miRNAs was selected from RNA sequencing and qRT-PCR and single-strand mimics of these miRNAs were delivered in the 2.5% dextran sodium sulfate colitis model to determine the effect. Histologic grading and immunohistochemistry evaluation and flow cytometry analyses were performed. Results From the prospective study cohort of CD and non-IBD healthy control (mean follow-up period of 13.06 months), we found a distinct array of miRNAs between groups. Small-RNA sequencing of CD patients in remission and active state (both in inflamed and non-inflamed tissue) revealed distinct microRNA profiles. Through qRT-PCR validation, we found that the expression levels of miR-141-3p, miR-338-3p, miR-378a-3p, and miR-200b-3p were significantly decreased, while miR-125b-5p, miR-29b-3p and miR-155-5p were significantly increased in the inflamed tissue of active CD patients. ROC curve analysis of these miRNAs suggested that they have varying diagnostic activities related to both clinical disease activity and endoscopic inflammation status. In an IBD animal model, the delivery of miR-338-3p and miR-378-3p demonstrated an anti-inflammatory effect, as evidenced both histologically and in immunohistochemistry data, as well as in flow cytometry analyses. Consistent results were observed when these two miRNAs were combined. Conclusion We report miR-338-3p and miR-378a-3p as distinct features in mucosa of CD patients and these data support the promising future of use of these miRNAs as potential therapeutic targets for novel IBD therapies.

gastroenterology & hepatology
microRNA–mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease

Carina de F. de Síbia,Ana E. V. Quaglio,Ellen C. S. de Oliveira,Jéssica N. Pereira,Jovita R. Ariede,Rainer M. L. Lapa,Fábio E. Severino,Patricia P. Reis,Lígia Y. Sassaki,Rogerio Saad-Hossne

DOI: https://doi.org/10.3390/biomedicines12020422

IF: 4.757

2024-02-13

Biomedicines

Abstract:The molecular processes linked to the development and progression of Crohn's disease (CD) and ulcerative colitis (UC) are not completely understood. MicroRNAs (miRNAs) regulate gene expression and are indicated as diagnostic, prognostic, and predictive biomarkers in chronic degenerative diseases. Our objectives included the identification of global miRNA expression in CD and UC, as well as miRNA target genes, miRNA–mRNA interaction networks, and biological functions associated with these different forms of inflammatory bowel disease (IBD). Methods: By performing a comprehensive meta-analysis, we integrated miRNA expression data from nine studies in IBD. We obtained detailed information on significantly deregulated miRNAs (fold change, FC ≥ 2 and p < 0.05), sample type and number, and platform applied for analysis in the training and validation sets. Further bioinformatic analyses were performed to identify miRNA target genes, by using the microRNA Data Integration Portal tool. We also sought to identify statistically enriched pathways of genes regulated by miRNAs using ToppGene Suite. Additional analyses were performed to filter for genes expressed in intestinal tissue using the European Bioinformatics Institute (EBI) database. Results: Our findings showed the upregulation of 15 miRNAs in CD and 33 in UC. Conversely, six miRNAs were downregulated in CD, while seven were downregulated in UC. These results indicate a greater deregulation of miRNAs in UC compared to CD. Of note, miRNA target genes were enriched for immune system regulation pathways. Among significantly deregulated miRNAs with a higher number of miRNA–target gene interactions, we identified miR-199a-5p and miR-362-3p altered in CD, while among UC case patients, miRNA–target gene interactions were higher for miR-155-5p. Conclusions: The identified miRNAs play roles in regulating genes associated with immune system regulation and inflammation in IBD. Such miRNAs and their target genes have the potential to serve as clinically relevant biomarkers. These findings hold promise for enhancing the accuracy of diagnoses and facilitating the development of personalized treatment strategies for individuals with various forms of IBD.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer

Pilar Chacon-Millan,Stefania Lama,Nunzio Del Gaudio,Antonietta Gerarda Gravina,Alessandro Federico,Raffaele Pellegrino,Amalia Luce,Lucia Altucci,Angelo Facchiano,Michele Caraglia,Paola Stiuso

DOI: https://doi.org/10.3390/ijms25115699

IF: 5.6

2024-05-24

International Journal of Molecular Sciences

Abstract:Ulcerative colitis (UC), an inflammatory bowel disease (IBD), may increase the risk of colorectal cancer (CRC) by activating chronic proinflammatory pathways. The goal of this study was to find serum prediction biomarkers in UC to CRC development by combining low-density miRNA microarray and biocomputational approaches. The UC and CRC miRNA expression profiles were compared by low-density miRNA microarray, finding five upregulated miRNAs specific to UC progression to CRC (hsa-let-7d-5p, hsa-miR-16-5p, hsa-miR-145-5p, hsa-miR-223-5p, and hsa-miR-331-3p). The circRNA/miRNA/mRNA competitive endogenous RNA (ceRNA) network analysis showed that the candidate miRNAs were connected to well-known colitis-associated CRC ACVR2A, SOCS1, IGF2BP1, FAM126A, and CCDC85C mRNAs, and circ-SHPRH circRNA. SST and SCARA5 genes regulated by hsa-let-7d-5p, hsa-miR-145-5p, and hsa-miR-331-3p were linked to a poor survival prognosis in a CRC patient dataset from The Cancer Genome Atlas (TCGA). Lastly, our mRNA and miRNA candidates were validated by comparing their expression to differentially expressed mRNAs and miRNAs from colitis-associated CRC tissue databases. A high level of hsa-miR-331-3p and a parallel reduction in SOCS1 mRNA were found in tissue and serum. We propose hsa-miR-331-3p and possibly hsa-let-7d-5p as novel serum biomarkers for predicting UC progression to CRC. More clinical sample analysis is required for further validation.

biochemistry & molecular biology,chemistry, multidisciplinary
Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats

Ping Wang,Yan Chen,La-Mei Zhang,Si-Qi Yuan,Shen-Ao Lu,Ying-Jian Zhang

DOI: https://doi.org/10.1016/j.lfs.2021.119603

IF: 6.78

2021-08-01

Life Sciences

Abstract:Multidrug resistance gene (MDR1a) and P-glycoprotein (P-gp) play an important role in the development of ulcerative colitis (UC) and influence the therapeutic effect of glucocorticoids, which may lead to drug resistance mechanically. UC may be related to miR-145 to some extent, and the relationship still needs further exploration. In this study we found that the expression of miR-145 was downregulated in the colonic tissues of rats with Dextran sodium sulfate (DSS)-induced UC. Also, the expression of MDR1a in colon tissues of each group negatively correlated with the expression of miR-145 in rats. The change in the plasma peak concentration (Cmax) in each group positively related to the miR-145 level. Mechanistically, miR-145 negatively regulated the expression and function of P-gp via acting directly on the 3′-UTR of MDR1 mRNA. Overall, these results indicated that miR-145 had a protective effect on the colorectal mucosa, and its downregulation may enhance the expression and function of MDR1a and P-gp, promoting the occurrence and development of UC. The downregulation of miR-145 reduced the drug sensitivity of 5-aminosalicylic acid (5-ASA) and glucocorticoids in treating UC, indicating that miR-145 might be a potential therapeutic target for UC.

pharmacology & pharmacy,medicine, research & experimental
Fibrinogen, FDP and D-Dimer as Potential Biomarkers for Disease Severity in Ulcerative Colitis: A Retrospective Study

Wan Feng,Lei Zhu,Song Zhao,Kai Zheng,Luzhou Xu,Hong Shen

DOI: https://doi.org/10.2147/ijgm.s477285

IF: 2.145

2024-11-28

International Journal of General Medicine

Abstract:Wan Feng, Lei Zhu, Song Zhao, Kai Zheng, Luzhou Xu, Hong Shen Department of Gastroenterology, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine), Nanjing, People's Republic of China Correspondence: Luzhou Xu; Hong Shen, Department of Gastroenterology, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing, 210029, People's Republic of China, Email ; Purpose: Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease that primarily affects the large intestine. Coagulation abnormalities have been detected in UC patients. This study aimed to evaluate coagulation-related parameters in patients with UC. Patients and Methods: A total of 364 UC patients were analyzed with 163 female and 201 male. Disease activity was determined according to the Truelove and Witts criteria. The fibrinogen (FIB), D-dimer, fibrin/fibrinogen degradation products (FDP), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels were evaluated. Results: We found higher D-dimer, FDP, FIB levels in severe UC compared with non-severe patients.The area under the curve (AUC) of D-dimer was 0.852 (95% CI 0.805 to 0.898) and the optimum cut-off point was 0.585, with a sensitivity of 80.6% and a specificity of 78.9%. Furthermore, D-dimer and FIB are positively correlated with ESR and CRP levels. Conclusion: Our results indicate that D-dimer, FDP, and FIB levels are potential biomarkers for disease severity in UC patients. Keywords: ulcerative colitis, D-dimer, fibrinogen, disease activity Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease that primarily affects the large intestine. The incidence of UC is increasing rapidly in China. It is characterized by relapsing and remitting mucosal inflammation. 1,2 Coagulation abnormalities have been detected in UC patients. Inflammatory bowel disease (IBD) is associated with a high risk of venous thromboembolism (VTE). 3–5 Several studies have indicated that IBD is associated with an approximately 2–3 fold elevated risk of VTE compared to healthy controls. 6,7 Venous thromboembolic events in UC patients are associated with significant morbidity and mortality. D-dimer and fibrin/fibrinogen degradation products (FDP) are involved in many diseases, such as aortic dissection, rheumatoid arthritis, coronavirus disease, severe acute pancreatitis, and cancer. Coagulation parameters play a role in evaluating diseases activity and have prognostic significance. 8–16 Recent evidence indicated that D-dimer levels are related to gut inflammation. 17 The results regarding the relationship between UC activity and coagulation parameters have been inconsistent. Our study aimed to evaluate the coagulation parameters such as fibrinogen (FIB), D-dimer, and FDP among UC patients and its association with disease severity. We retrospectively analyzed the electronic medical records of patients with UC admitted to the Jiangsu Province Hospital of Chinese Medicine. This study recruited 364 UC patients between January 2018 and July 2022. UC is diagnosed on the basis of clinical presentation,endoscopic and histopathological findings. 18 We included hospitalized adult patients for whom demographic, clinical, and laboratory data could be obtained. Coagulation parameters, including FIB, FDP, and D-dimer levels were collected. The exclusion criteria were as follows: pregnancy, Crohn's disease (CD), indeterminate colitis, age < 18 years, and incomplete laboratory data. The Truelove and Witts criteria was used to evaluate disease activity. Patients were classified as mild, moderate, and severe based on the bloody stool frequency, temperature, heart rate, hemoglobin, and erythrocyte sedimentation rate (ESR). 19,20 Disease extent was classified according to the Montreal Classification. Continuous variables are presented as median and interquartile range (IQR). Mann–Whitney and Kruskal–Wallis tests were used to determine the differences between the groups. Categorical variables are expressed as percentages, and the chi-square test was used for comparisons between groups. Spearman's correlation analysis was used to evaluate the association between the variables. Receiver operating characteristic (ROC) curves were plotted to differentiate severe from non-severe UC. P <0.05 was considered statistically significant. Data were statistically analyzed using SPSS 25.0. In total, 364 patients with UC were enrolled in this study. The median age was 46 (IQR 34–58) years, ranging from 18 to 78 years. This study included 201 males and 163 females. Of 364 patients, 183 (50.3%) had extensive colitis. 76.9% were taking oral 5-aminosalicylic acid (5- -Abstract Truncated-

medicine, general & internal
MicroRNA-146a limits tumorigenic inflammation in colorectal cancer

Lucien P. Garo,Amrendra K. Ajay,Mai Fujiwara,Galina Gabriely,Radhika Raheja,Chantal Kuhn,Brendan Kenyon,Nathaniel Skillin,Ryoko Kadowaki-Saga,Shrishti Saxena,Gopal Murugaiyan

DOI: https://doi.org/10.1038/s41467-021-22641-y

IF: 16.6

2021-04-23

Nature Communications

Abstract:Abstract Chronic inflammation can drive tumor development. Here, we have identified microRNA-146a (miR-146a) as a major negative regulator of colonic inflammation and associated tumorigenesis by modulating IL-17 responses. MiR-146a-deficient mice are susceptible to both colitis-associated and sporadic colorectal cancer (CRC), presenting with enhanced tumorigenic IL-17 signaling. Within myeloid cells, miR-146a targets RIPK2, a NOD2 signaling intermediate, to limit myeloid cell-derived IL-17-inducing cytokines and restrict colonic IL-17. Accordingly, myeloid-specific miR-146a deletion promotes CRC. Moreover, within intestinal epithelial cells (IECs), miR-146a targets TRAF6, an IL-17R signaling intermediate, to restrict IEC responsiveness to IL-17. MiR-146a within IECs further suppresses CRC by targeting PTGES2, a PGE2 synthesis enzyme. IEC-specific miR-146a deletion therefore promotes CRC. Importantly, preclinical administration of miR-146a mimic, or small molecule inhibition of the miR-146a targets, TRAF6 and RIPK2, ameliorates colonic inflammation and CRC. MiR-146a overexpression or miR-146a target inhibition represent therapeutic approaches that limit pathways converging on tumorigenic IL-17 signaling in CRC.

multidisciplinary sciences
Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease

Lu Yi Wu,Xiao Peng Ma,Yin Shi,Chun Hui Bao,Xiao Ming Jin,Yuan Lu,Ji Meng Zhao,Ci Li Zhou,Dai Chen,Hui Rong Liu

DOI: https://doi.org/10.1111/jgh.13778

2017-09-26

Journal of Gastroenterology and Hepatology

Abstract:BACKGROUND AND AIM: The microRNA (miRNA) expression profiles of the terminal ileum, sigmoid colon, and rectal mucosa of adult patients with active Crohn's disease (CD) have been previously reported. The purpose of this study was to identify dysregulated miRNAs in the mucosa of the ascending colon.METHODS: Biopsy tissue samples were taken from the mucosae of inflammatory (iCD) or noninflammatory (niCD) areas of the ascending colons of adult patients with active CD. miRNA and mRNA expression profiles were detected using microarray analyses. miRNAs and messenger RNAs (mRNAs) demonstrating significant differences were validated via quantitative real-time polymerase chain reaction. Luciferase reporter genes were used to measure two miRNAs inhibition of potential target genes in human 293T cells in vitro.RESULTS: Compared with the healthy control group, the ascending colon miRNA expression profiles revealed that 43 miRNAs were significantly upregulated and 35 were downregulated in the iCD group. The mRNA expression profiles indicated that 3370 transcripts were significantly differentially expressed in the ascending colon, with 2169 upregulated and 1201 downregulated mRNAs in the iCD group, and only 20 miRNAs demonstrated significant differential expression in the niCD group. In contrast, nearly 100 miRNAs significantly varied between the iCD and niCD groups. Finally, luciferase reporter gene assays showed that hsa-miR-16-1 directly regulated the human C10orf54 gene and that they were negatively correlated.CONCLUSIONS: Our results indicated that the differentially expressed miRNAs and mRNAs were related to immune inflammation and intestinal flora. The data provide preliminary evidence that the occurrence of CD involves the inhibition of C10orf54 expression by hsa-miR-16-1.

gastroenterology & hepatology
MiR-146a alleviates inflammatory bowel disease in mice through systematic regulation of multiple genetic networks

Fengting Zhu,Taotan Yang,Mengmeng Ning,Yang Liu,Wei Xia,Yan Fu,Ting Wen,Mei Zheng,Ruilong Xia,Ran Qian,Yang Li,Minxuan Sun,Jianping Liu,Li Tian,Qian Zhou,Xin Yu,Changgeng Peng

DOI: https://doi.org/10.3389/fimmu.2024.1366319

2024-05-10

Abstract:Introduction: Inflammatory bowel disease (IBD) is a chronic disease involving multiple genes, and the current available targeted drugs for IBD only deliver moderate efficacy. Whether there is a single gene that systematically regulates IBD is not yet known. MiR-146a plays a pivotal role in repression of innate immunity, but its function in the intestinal inflammation is sort of controversy, and the genetic regulatory networks regulated by miR-146a in IBD has not been revealed. Methods: RT-qPCR was employed to detect the expression of miR-146a in IBD patients and in a mouse IBD model induced by dextran sulfate sodium (DSS), and then we generated a miR-146a knock-out mouse line with C57/Bl6N background. The disease activity index was scored in DSS-treated miR-146a deficiency mice and their wild type (WT) littermates. Bulk RNA-sequencing, RT-qPCR and immunostaining were done to illustrate the downstream genetic regulatory networks of miR-146a in flamed colon. Finally, the modified miR-146a mimics were used to treat DSS-induced IBD in miR-146a knock-out and WT IBD mice. Results: We showed that the expression of miR-146a in the colon was elevated in dextran sulfate sodium (DSS)-induced IBD mice and patients with IBD. DSS induced dramatic body weight loss and more significant rectal bleeding, shorter colon length, and colitis in miR-146a knock-out mice than WT mice. The miR-146a mimics alleviated DSS-induced symptoms in both miR-146a-/- and WT mice. Further RNA sequencing illustrated that the deficiency of miR-146a de-repressed majority of DSS-induced IBD-related genes that cover multiple genetic regulatory networks in IBD, and supplementation with miR-146a mimics inhibited the expression of many IBD-related genes. Quantitative RT-PCR or immunostaining confirmed that Ccl3, Saa3, Csf3, Lcn2, Serpine1, Serpine2, MMP3, MMP8, MMP10, IL1A, IL1B, IL6, CXCL2, CXCL3, S100A8, S100A9, TRAF6, P65, p-P65, and IRAK1 were regulated by miR-146a in DSS induced IBD. Among them, MMP3, MMP10, IL6, IL1B, S100A8, S100A9, SERPINE1, CSF3, and IL1A were involved in the active stage of IBD in humans. Discussion: Our date demonstrated that miR-146a acts as a top regulator in C57/BL6N mice to systematically repress multiple genetic regulatory networks involved in immune response of intestine to environment factors, and combinatory treatment with miR-146a-5p and miR-146a-3p mimics attenuates DSS-induced IBD in mice through down-regulating multiple genetic regulatory networks which were increased in colon tissue from IBD patients. Our findings suggests that miR-146a is a top inhibitor of IBD, and that miR-146a-5p and miR-146a-3p mimics might be potential drug for IBD.
miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go

Danusia Onisor,Olga Brusnic,Claudia Banescu,Claudia Carstea,Maria Sasaran,Mircea Stoian,Calin Avram,Adrian Boiceanu,Alina Boeriu,Daniela Dobru

DOI: https://doi.org/10.3390/biomedicines12061315

IF: 4.757

2024-06-14

Biomedicines

Abstract:(1) Elucidating the role of miRNAs (miRs) in ulcerative colitis may provide new insights into disease pathogenesis, diagnosis, treatment, and monitoring We aimed to investigate whether plasma levels of miR-21-5p and miR-155-5p may be used to differentiate between patients with organic disease such as ulcerative colitis (UC) and Clostridioides difficile infection (CDI), and patients with functional disease such as irritable bowel syndrome with diarrhea (IBS-D). (2) Serological samples were collected to quantify miR-155 and -21 expression, which was carried out through quantitative real-time polymerase chain reaction (qRT-PCR), from 84 patients: 34 with acute UC (group 1), 17 with CDI (group 2), and 33 with IBS-D (control group). (3) In this study, we found that the expression levels of miR-155-5p were almost the same for the two conditions and the control group (UC: 4.22 ± 1.61, CDI: 3.94 ± 1.62, IBS-D: 4.26 ± 1.26), with no significant differences either for ΔCt- or for ΔΔCt-derived parameters (p = 0.74 and p = 0.73, respectively). For miR-21, ΔCt levels presented significantly higher values among the ulcerative colitis group (p < 0.01), but the most important expression fold change was noticed in patients with CDI (UC:4.11 ± 8,46, CDI: 4.94 ± 9.68, IBS-D: 2.83 ± 5.41). (4) Circulating miR-155 and miR-21 were upregulated in UC, CDI, and IBS-D, but differentiation was not possible among them. But their involvement in the pathogenesis of the three diseases makes them suitable for improving the accuracy of diagnosis and facilitating the development of personalized treatment strategies.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis

Natalya Benderska,Anna-Lena Dittrich,Sabine Knaup,Tilman T Rau,Clemens Neufert,Sven Wach,Fabian B Fahlbusch,Manfred Rauh,Ralph M Wirtz,Abbas Agaimy,Swetha Srinivasan,Vijayalakshmi Mahadevan,Petra Rümmele,Emmanouela Rapti,Maria Gazouli,Arndt Hartmann,Regine Schneider-Stock

DOI: https://doi.org/10.1097/MIB.0000000000000453

Abstract:Background: Longstanding ulcerative colitis (UC) bears a high risk for development of UC-associated colorectal carcinoma (UCC). The inflammatory microenvironment influences microRNA expression, which in turn deregulates target gene expression. microRNA-26b (miR-26b) was shown to be instrumental in normal tissue growth and differentiation. Thus, we aimed to investigate the impact of miR-26b in inflammation-associated colorectal carcinogenesis. Methods: Two different cohorts of patients were investigated. In the retrospective group, a tissue microarray with 38 samples from 17 UC/UCC patients was used for miR-26b in situ hybridization and quantitative reverse transcription polymerase chain reaction analyses. In the prospective group, we investigated miR-26b expression in 25 fresh-frozen colon biopsies and corresponding serum samples of 6 UC and 15 non-UC patients, respectively. In silico analysis, Ago2-RNA immunoprecipitation, luciferase reporter assay, quantitative reverse transcription polymerase chain reaction examination, and miR-26b mimic overexpression were employed for target validation. Results: miR-26b expression was shown to be upregulated with disease progression in tissues and serum of UC and UCC patients. Using miR-26b and Ki-67 expression levels, an UCC was predicted with high accuracy. We identified 4 novel miR-26b targets (DIP1, MDM2, CREBBP, BRCA1). Among them, the downregulation of the E3 ubiquitin ligase DIP1 was closely related to death-associated protein kinase stabilization along the normal mucosa-UC-UCC sequence. In silico functional pathway analysis revealed that the common cellular pathways affected by miR-26b are highly related to cancerogenesis and the development of gastrointestinal diseases. Conclusions: We suggest that miR-26b could serve as a biomarker for inflammation-associated processes in the gastrointestinal system. Because miR-26b expression is downregulated in sporadic colon cancer, it could discriminate between UCC and the sporadic cancer type.

[Treatment of chronic hypoxemia in COPD].

P021 Higher TNFα and IL-6 mucosal levels in ulcerative colitis patients with more severe endoscopic activity

Estimation of fertility-inhibiting indices using vital registration data.

[Kapandji-Sauvé procedure for chronic disorders of the distal radioulnar joint with special regard to the long-term results].

Investigation of key miRNAs and their target genes in inflammatory bowel diseases and colitis-associated colorectal cancers using miRNA proifling and bioinformatic tools

Investigating the association between the tissue expression of miRNA‐101, JAK2/STAT3 with TNF‐α, IL‐6, IL‐1β, and IL‐10 cytokines in the ulcerative colitis patients

P001 MicroRNA-155-5p contributes to the development of Ulcerative Colitis by regulating T lymphocyte proliferation and functions

The Expressions of IL-2, IL-4, IL-17 and IL-10 in Ulcerative Colitis (UC) Mucosa and Its Relation with Disease Activity

Explore on the Mechanism of miRNA-146a/TAB1 in the Regulation of Cellular Apoptosis and Inflammation in Ulcerative Colitis Based on NF-κB Pathway

MIR-21 regulating distribution of intestinal flora through TNF-α promotes progression of ulcerative colitis

miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

microRNA–mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease

A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer

Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats

Fibrinogen, FDP and D-Dimer as Potential Biomarkers for Disease Severity in Ulcerative Colitis: A Retrospective Study

MicroRNA-146a limits tumorigenic inflammation in colorectal cancer

Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease

MiR-146a alleviates inflammatory bowel disease in mice through systematic regulation of multiple genetic networks

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go

miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis